Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-01 Purchase | 2023-12-05 4:30 pm | Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner | 1,800,000 | $10 | $18,000,000 | 12,168,489 (Indirect) | View |
| 2022-11-04 Sale | 2022-11-08 5:51 pm | Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner | 48,583 | $31.14 | $1,512,806 | 4,308,630 (Indirect) | View |
| 2022-11-02 Sale | 2022-11-04 5:58 pm | Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner | 78,220 | $33.95 | $2,655,330 | 4,386,850 (Indirect) | View |
| 2022-10-31 Sale | 2022-11-02 9:02 pm | Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner | 85,659 | $37.95 | $3,250,496 | 4,472,510 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-11-09 Disposition | 2023-11-09 4:12 pm | N/A 2032-09-30 | EQRx Inc. | EQRX | Yeshwant Krishna Director | 101,010 | $0 | 0 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 5:00 pm | N/A 2033-06-14 | Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner | 26,642 | $0 | 26,642 (Direct) | View |
| 2022-11-04 Other | 2022-11-08 5:51 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner | 48,583 | $0 | 4,308,630 (Indirect) | View |
| 2022-11-02 Other | 2022-11-04 5:58 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner | 78,220 | $0 | 4,386,850 (Indirect) | View |
| 2022-10-31 Other | 2022-11-02 9:02 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner | 85,660 | $0 | 4,472,510 (Indirect) | View |
| 2022-09-30 Option Award | 2022-10-04 8:10 pm | N/A 2032-09-30 | EQRx Inc. | EQRX | Yeshwant Krishna Director | 101,010 | $0 | 101,010 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 5:01 pm | N/A 2032-06-08 | Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner | 15,500 | $0 | 15,500 (Direct) | View |
| 2021-06-21 Conversion | 2021-06-22 5:17 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner | 110,735,050 | $0 | 4,472,509 (Indirect) | View |
Ownership | 2021-06-16 7:40 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner | 0 | $0 | 10,793,414 (Indirect) | View |